The Suzano SA first quarter of 2025 conference call is concluded. The Investor Relations department is available to answer any further questions you may have. Thank you and have a good day.

AFRM's fiscal Q3 results benefit from improved repeat customer transactions and servicing income. It currently forecasts GMV ...

What a brutal six months it’s been for United Therapeutics. The stock has dropped 23.1% and now trades at $308, rattling many ...